Press release from Companies
Published: 2025-10-29 08:50:55
The following shareholders have been identified as the three largest shareholders as of 2025-09-30 who are willing to be part of the Nomination Committee and they have appointed the following members:
Swedia Invest AB: Lisa Tunon
David Zetterlund: Eric Tour
Marcel Warntjes: Marcel Warntjes
In total, the Nomination Committee represents approx. 41 percent of the total number of shares and votes in the company. Lisa Tunon and Eric Tour are independent in relation to the company and its executive management. Marcel Warntjes and Eric Tour are independent in relation to Swedia Invest AB, which is the largest shareholder in the company in terms of votes.
The Committee’s assignment is to present to the Annual General Meeting proposals regarding Chairman and other members of the board as well as remuneration to the Board ́s members. The Nomination Committee shall also submit proposals for appointment and remuneration of financial auditors. Further, the Committee shall submit proposals to the process to appoint the Nomination Committee for the AGM in 2027.
Shareholders who wish to submit proposals to the Nomination Committee can do so by email to Lisa Tunon: lisa@swediacapital.se .
SyntheticMR AB (publ) develops and markets innovative imaging solutions that enhance neuroimaging workflow efficiency and diagnostic precision. SyntheticMR’s SyMRI® solution measures brain absolute tissue properties and generates multiple contrast-weighted images, performs automatic segmentation of biomarkers, and delivers quantitative data in a single fast scan. Combinostics, a SyntheticMR company, offers the AI-powered cNeuro® suite of products that help clinicians make a difference in the lives of patients with neurological disorders. Our products are, among other things, CE-marked and FDA-approved, and we are listed on Spotlight Stock Market Exchange in Stockholm. SyntheticMR is headquartered in Linköping, Sweden, with an additional office in Tampere, Finland. For more information, please visit syntheticmr.com and combinostics.com.
